Search Results

The WALLSTENT RP Endoprosthesis Transhepatic Biliary and WALLSTENT Endoprosthesis Transhepatic Biliary are indicated for use in the treatment of biliary strictures produced by malignant neoplasms.

The WALLSTENTTM RP Endoprosthesis Transhepatic Biliary and WALLSTENTTM Endoprosthesis Transhepatic Biliary are comprised of two components: The implantable metallic stent and the Unistep Plus delivery system. The stent is composed of biomedical superalloy wire, braided in a tubular mesh configuration. This design configuration results in a stent that is flexible, compliant, and self-expanding. The delivery system consists in part of coaxial tubes. The exterior tube serves to constrain the stent until retracted during delivery. Radiopaque marker bands situated on the interior and exterior tubes aid in imaging during deployment. Small stent sizes (8 & 10mm) may have a radiopaque core to improve radiopacity. The interior tube of the coaxial system contains a central lumen that accommodates a 0.035in (0.89mm) guidewire.

This document does not contain information about an AI/ML medical device, but rather a medical device called the WALLSTENT RP Endoprosthesis Transhepatic Biliary and WALLSTENT Endoprosthesis Transhepatic Biliary, which is a self-expanding metallic stent used to treat biliary strictures produced by malignant neoplasms.

Therefore, I cannot answer the questions regarding acceptance criteria and the study that proves an AI/ML device meets the acceptance criteria, as the provided text does not describe such a device or study.

The document indicates that the device undergoes bench testing to support MR Conditional labeling, and this testing provides assurance of conformance to requirements for its intended use. However, these are not the types of studies typically conducted for AI/ML devices proving clinical performance with metrics like sensitivity, specificity, or reader improvement.

Ask a specific question about this device